Biohaven

BHVN • NYSE • Stock Fundamentals

Biohaven is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Vladimir Coric, with a market cap of $1.7B.

Market Cap$1.7B

Employees239.0

CEOVladimir Coric

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Biohaven

Biohaven (BHVN) has a market capitalization of $1.7B and trades on NYSE.

Biohaven has approximately 239 employees.